✦ LIBER ✦

Refinement of the Population Pharmacokinetic Model for the Monoclonal Antibody Matuzumab

✍ Scribed by Katharina Kuester, Andreas Kovar, Christian Lüpfert, Brigitte Brockhaus, Prof. Charlotte Kloft

Book ID: 119930587
Publisher: Springer International Publishing AG
Year: 2009
Tongue: English
Weight: 672 KB
Volume: 48
Category: Article
ISSN: 0312-5963
DOI: 10.2165/11313400-000000000-00000

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Population Pharmacokinetic/Pharmacodynam

Population Pharmacokinetic/Pharmacodynamic Analyses as the Basis for Dosing of Therapeutic Monoclonal Antibodies

✍ Dr Bernd Meibohm 📂 Article 📅 2011 🏛 Springer International Publishing AG 🌐 English ⚖ 89 KB

Animal models for the evaluation of labe

Animal models for the evaluation of labeled monoclonal antibodies

✍ Welch, Michael J.; Otsuka, F.L. 📂 Article 📅 1986 🏛 Elsevier Science ⚖ 101 KB

Monoclonal antibodies: what are the phar

Monoclonal antibodies: what are the pharmacokinetic and pharmacodynamic considerations for drug development?

✍ Deng, Rong; Jin, Feng; Prabhu, Saileta; Iyer, Suhasini 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 514 KB

Assessment of the validity of a populati

Assessment of the validity of a population pharmacokinetic model for epirubicin

✍ Lorraine D. Ralph; Marie Sandstrom; Chris Twelves; Nicola A. Dobbs; Alison H. Th 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 180 KB

Phase I study of the humanised anti-EGFR

Phase I study of the humanised anti-EGFR monoclonal antibody matuzumab (EMD 72000) combined with gemcitabine in advanced pancreatic cancer

✍ Graeven, U; Kremer, B; Südhoff, Th; Killing, B; Rojo, F; Weber, D; Tillner, J; ü 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 160 KB

Binding of the neuroleptic drug haloperi

Binding of the neuroleptic drug haloperidol to a monoclonal antibody: Refinement of the binding site molecular model using canonical structures

✍ Jerry M. Anchin; Shankar Subramaniam; D. Scott Linthicum 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 813 KB

The ligand binding site of a monoclonal antibody (185), which binds the neuroleptic drug haloperidol, has been modelled using canonical structures and energy minimization techniques. This refined modelling protocol has allowed us to predict the variable region loop conformations. Three key residues,